Artiva Biotherapeutics Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Artiva Biotherapeutics Inc. | ARTV - NASDAQ |
$14.00-$16.00 | $12.00 | $16.00 | 13.9 million | 7/19/2024 |
| Jefferies, TD Cowen, Cantor | ||||||
Co-Manager(s): Wedbush PacGrow, Needham & Co.
| ||||||
| Health Care | ||||||
Filing(s): Filed 2024-06-28 Terms Added 2024-07-15 | ||||||
Artiva Biotherapeutics Inc. Quote & Chart - Click for current quote - ARTV
IPO Boutique aggregates information on public companies and private companies, such as "ARTV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Artiva Biotherapeutics Inc. (adapted from Artiva Biotherapeutics Inc. prospectus):
They deliver highly effective, off-the-shelf, allogeneic, natural killer (NK) cell-based therapies that are safe and accessible to cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They deliver highly effective, off-the-shelf, allogeneic, natural killer (NK) cell-based therapies that are safe and accessible to cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ARTV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.